Emerging Role of Carfilzomib in Treatment of Relapsed and Refractory Lymphoid Neoplasms and Multiple Myeloma
Core Evidence - New Zealand
doi 10.2147/ce.s13838
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2011
Authors
Publisher
Informa UK Limited